Tuesday, March 18, 2025 | 06:14 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Board of Krebs Biochemicals & Industries approves preferential allotment of shares & warrants

Image

Capital Market

At meeting held on 03 October 2015

Krebs Biochemicals & Industries announced the Board of Directors of the Company at its meeting held on 03 October 2015, inter alia, has considered and approved the following items of business:

- Allotment of 650,000 equity shares of face value of Rs. 10/- each at a price of Rs. 54/- per share (including premium of Rs. 44/- per share) and 680,000 convertible warrants each of which is convertible into one equity share of face value of Rs. 10/- at a price of Rs. 54/- per share (including premium of Rs. 44/- per share) on preferential basis to Hemalata Ravi, Promoter of the Company.

 

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 03 2015 | 4:14 PM IST

Explore News